Increased experimental metastatic capacity of a murine melanoma following induction of differentiation.
暂无分享,去创建一个
E. Ormerod | D. Bennett | T. Dexter | I. Hart
[1] V. Ling,et al. Quantitative genetic analysis of tumor progression , 2004, Cancer and Metastasis Reviews.
[2] J. Sirácky,et al. Relationship between melanogenesis, proliferative activity and response to chemotherapy of human melanoma xenografts. , 1984, Neoplasma (Bratislava).
[3] A. Bloch. Induced cell differentiation in cancer therapy. , 1984, Cancer treatment reports.
[4] D. Bennett,et al. Differentiation in mouse melanoma cells: Initial reversibility and an on-off stochastic model , 1983, Cell.
[5] E. Stanbridge,et al. The role of differentiation in the suppression of tumorigenicity in human cell hybrids , 1982, International journal of cancer.
[6] G. Poste,et al. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases. , 1982, Cancer research.
[7] G. B. Pierce,et al. Specificity of the control of tumor formation by the blastocyst. , 1982, Cancer research.
[8] L. Sachs. Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[9] V. Hruby,et al. 4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[10] I. Weinstein,et al. Identification of a distinct phase during melanogenesis that is sensitive to extracellular pH and ionic strength , 1980, Journal of cellular physiology.
[11] Y. Honma,et al. Prolongation of survival time of mice inoculated with myeloid leukemia cells by inducers of normal differentiation. , 1979, Cancer research.
[12] D. Viskochil,et al. The role of RNA and protein synthesis in mediating the action of MSH on mouse melanoma cells. , 1979, Life sciences.
[13] R. Niles,et al. Hormonal activation of adenylate cyclase in mouse melanoma metastatic variants , 1978, Journal of cellular physiology.
[14] Y. Honma,et al. Relationship between leukemogenicity and in vivo inducibility of normal differentiation in mouse myeloid leukemia cells. , 1978, Journal of the National Cancer Institute.
[15] J. Sedmak,et al. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. , 1977, Analytical biochemistry.
[16] L. Sachs,et al. Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture , 1975, Journal of cellular physiology.
[17] I. Fidler,et al. Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.
[18] G. S. Johnson,et al. N 6 ,O 2 '-dibutyryl adenosine 3',5'-monophosphate induces pigment production in melanoma cells. , 1972, Nature: New biology.
[19] W. Scher,et al. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[20] S. A. Bruce,et al. Suppression of malignancy and differentiation in melanotic melanoma cells. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Pomerantz. The tyrosine hydroxylase activity of mammalian tyrosinase. , 1966, The Journal of biological chemistry.